Bai Y, Reid J, Habbous S, Devlin R, Jaakkimainen L, Sarma S
Eur J Health Econ. 2024; .
PMID: 39652221
DOI: 10.1007/s10198-024-01745-4.
Bartolome-Moreno C, Melus-Palazon E, Vela-Vallespin C, Arana-Ballestar S, Gallego M, Navarro J
Aten Primaria. 2024; 56 Suppl 1():103128.
PMID: 39613364
PMC: 11705588.
DOI: 10.1016/j.aprim.2024.103128.
Jeong S, Choi Y
Nutrients. 2024; 16(7).
PMID: 38613081
PMC: 11013844.
DOI: 10.3390/nu16071048.
Kang E, Ju H, Kim S, Choi J
BMC Public Health. 2024; 24(1):942.
PMID: 38566004
PMC: 10985908.
DOI: 10.1186/s12889-024-18403-2.
Dasgupta P, Cameron J, Goodwin B, Cramb S, Mengersen K, Aitken J
PLoS One. 2023; 18(7):e0288992.
PMID: 37471422
PMC: 10358922.
DOI: 10.1371/journal.pone.0288992.
[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022].
Marzo-Castillejo M, Bartolome-Moreno C, Bellas-Beceiro B, Melus-Palazon E, Vela-Vallespin C
Aten Primaria. 2022; 54 Suppl 1:102440.
PMID: 36435580
PMC: 9705215.
DOI: 10.1016/j.aprim.2022.102440.
What factors empower general practitioners for early cancer diagnosis? A 20-country European Delphi Study.
Tzanis G, Harris M, Brekke M, Marzo-Castillejo M, Cifcili S, Wawrzynek W
Prim Health Care Res Dev. 2022; 23:e76.
PMID: 36426593
PMC: 9706379.
DOI: 10.1017/S1463423622000652.
Advances in and the Applicability of Machine Learning-Based Screening and Early Detection Approaches for Cancer: A Primer.
Benning L, Peintner A, Peintner L
Cancers (Basel). 2022; 14(3).
PMID: 35158890
PMC: 8833439.
DOI: 10.3390/cancers14030623.
Does Direct-to-Consumer Personal Genetic Testing Improve Gynecological Cancer Screening Uptake among Never-Screened Attendees? A Randomized Controlled Study.
Watanabe M, Hosono S, Nakagawa-Senda H, Yamamoto S, Aoyama M, Hattori S
Int J Environ Res Public Health. 2021; 18(23).
PMID: 34886058
PMC: 8657107.
DOI: 10.3390/ijerph182312333.
Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment.
Zhao Z, Du L, Wang L, Wang Y, Yang Y, Dong H
Cancers (Basel). 2021; 13(23).
PMID: 34885217
PMC: 8656503.
DOI: 10.3390/cancers13236110.
Socioeconomic Determinants of Participation in Cancer Screening in Argentina: A Cross-Sectional Study.
Nuche-Berenguer B, Sakellariou D
Front Public Health. 2021; 9:699108.
PMID: 34504827
PMC: 8423085.
DOI: 10.3389/fpubh.2021.699108.
Intentions to undergo primary screening with colonoscopy under the National Cancer Screening Program in Korea.
Lee K, Seo H, Choe S, Jeong S, Park J, Suh M
PLoS One. 2021; 16(2):e0247252.
PMID: 33626070
PMC: 7904222.
DOI: 10.1371/journal.pone.0247252.
Perspectives and practices of cancer screening among workers at a tertiary health facility in Nigeria: indications for adaptation and integration of best practices.
Eze G, Obiebi I
Ghana Med J. 2019; 53(3):226-236.
PMID: 31741495
PMC: 6842732.
DOI: 10.4314/gmj.v53i3.7.
The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review.
John N, Wright S, Gavan S, Vass C
Eur J Health Econ. 2019; 20(8):1123-1131.
PMID: 31230226
PMC: 6803567.
DOI: 10.1007/s10198-019-01082-x.
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht J, Mayo-de-Las-Casas C, Berenguer J, Karachaliou N, Rosell R
Curr Oncol Rep. 2018; 20(9):70.
PMID: 30030656
DOI: 10.1007/s11912-018-0720-z.
Development of an evidence-based brief 'talking' intervention for non-responders to bowel screening for use in primary care: stakeholder interviews.
Cavers D, Calanzani N, Orbell S, Vojt G, Steele R, Brownlee L
BMC Fam Pract. 2018; 19(1):105.
PMID: 29960599
PMC: 6026505.
DOI: 10.1186/s12875-018-0794-6.
Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
Holloway C, Jiang L, Whitehead M, Racz J, Groome P
J Cancer Res Clin Oncol. 2018; 144(9):1769-1775.
PMID: 29909564
DOI: 10.1007/s00432-018-2687-4.
Predictors of Colorectal Cancer Knowledge among Adults in the United Arab Emirates.
Al-Sharbatti S, Muttappallymyalil J, Sreedharan J, Almosawy Y
Asian Pac J Cancer Prev. 2017; 18(9):2355-2359.
PMID: 28950678
PMC: 5720636.
DOI: 10.22034/APJCP.2017.18.9.2355.
Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention.
Lonnberg S, Andreassen T, Engesaeter B, Lilleng R, Kleven C, Skare A
BMJ Open. 2017; 6(11):e013728.
PMID: 28186949
PMC: 5128903.
DOI: 10.1136/bmjopen-2016-013728.
Improving self-management of cancer risk factors, underscreening for cancer and depression among general practice patients: study protocol of a randomised controlled trial.
Carey M, Sanson-Fisher R, Oldmeadow C, Mansfield E, Walsh J
BMJ Open. 2016; 6(11):e014782.
PMID: 27864255
PMC: 5128774.
DOI: 10.1136/bmjopen-2016-014782.